Cubist Systematic Strategies, LLC Adaptive Biotechnologies Corp Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 299,281 shares of ADPT stock, worth $1.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

299,281

Holding current value

$1.7 Million

% of portfolio

0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.37 - $5.12 $1.01 Million - $1.53 Million	299,281 New	299,281 $1.53 Million
Q1 2024 May 15, 2024	SELL	$2.88 - $4.8 $109,385 - $182,308	-37,981 Reduced 42.92%	50,502 $162,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $306,151 - $471,614	88,483 New	88,483 $433,000
Q1 2023 May 15, 2023	SELL	$7.8 - $10.11 $3.1 Million - $4.02 Million	-397,982 Reduced 67.15%	194,705 $1.72 Million
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $690,966 - $1.03 Million	110,378 Added 22.89%	592,687 $4.53 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $1.07 Million - $2.09 Million	164,982 Added 51.99%	482,309 $3.43 Million
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $47,852 - $110,136	7,477 Added 2.41%	317,327 $2.57 Million
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $2.24 Million - $6.39 Million	221,235 Added 249.66%	309,850 $4.3 Million
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $1.16 Million - $1.7 Million	46,082 Added 108.34%	88,615 $2.49 Million
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $535,046 - $710,603	17,823 Added 72.13%	42,533 $1.45 Million
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $1.9 Million - $2.63 Million	-59,054 Reduced 70.5%	24,710 $1.01 Million
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $2.9 Million - $5.27 Million	77,844 Added 1314.93%	83,764 $3.37 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $118,691 - $172,644	2,637 Added 80.32%	5,920 $350,000
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $2,970 - $4,051	83 Added 2.59%	3,283 $160,000
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $508,031 - $985,113	-20,362 Reduced 86.42%	3,200 $155,000
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $399,611 - $804,877	23,562 New	23,562 $655,000

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $812M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Adaptive Biotechnologies Corp Transaction History